The Chromultra Chromosome SNP HD Microarray Test is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to detect chromosomal abnormalities and single nucleotide polymorphisms (SNPs) with high precision. This test is particularly useful for identifying genetic disorders, understanding inherited conditions, and providing crucial information for personalized medicine approaches. By analyzing DNA samples, the Chromultra test can pinpoint variations and mutations that may be responsible for genetic diseases, offering insights that are vital for early detection, management, and treatment planning. The test is priced at 5850 AED, reflecting its comprehensive nature and the advanced technology it employs to deliver detailed genetic insights.
The Comprehensive Hereditary Cancer Panel 104 Genes Test, available at DNA Labs UAE for a cost of 5850 AED, is a cutting-edge genetic screening tool designed to assess an individual's risk for various types of hereditary cancers. This test examines 104 specific genes that have been scientifically linked to an increased risk of developing cancer, including but not limited to breast, ovarian, colorectal, and prostate cancers. By analyzing an individual's DNA, the test identifies genetic mutations that could predispose them to cancer, enabling early detection strategies or preventive measures to be implemented. This comprehensive approach to genetic testing is crucial for individuals with a family history of cancer, offering them invaluable insights into their genetic health and empowering them with information to make informed decisions regarding their healthcare and lifestyle choices. DNA Labs UAE provides this service with the utmost confidentiality and support, ensuring that individuals receive comprehensive counseling and guidance throughout the testing process.
The Spinocerebellar Ataxia (SCA) Extended Profile Test is a comprehensive genetic screening aimed at identifying mutations associated with various forms of Spinocerebellar Ataxia, a progressive, neurodegenerative disorder characterized by coordination and balance difficulties. This condition encompasses a group of genetic disorders that affect the cerebellum, the part of the brain that controls muscle coordination.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test covers a wide array of SCA subtypes, providing a thorough assessment for individuals experiencing symptoms or those with a family history of the condition. The test is particularly crucial for early detection, family planning, and to guide clinical management of the disorder.
The cost of the SCA Extended Profile Test is set at 4000 AED. This investment includes a detailed analysis of the patient's DNA to identify specific genetic mutations linked to the different types of Spinocerebellar Ataxia. The results from this test can offer valuable insights into the specific subtype of SCA, if present, and thereby inform more targeted and effective treatment strategies.
DNA Labs UAE employs cutting-edge technology and adheres to stringent quality standards to ensure the accuracy and reliability of test results. Given the complexity of SCA and the importance of genetic factors in its diagnosis and management, the SCA Extended Profile Test represents a critical step forward for individuals seeking answers and options for managing this challenging condition.
Criggler Najjar Syndrome Test is a specialized diagnostic assessment aimed at detecting Crigler-Najjar syndrome, a rare genetic disorder characterized by an inability to properly process bilirubin, leading to jaundice and potentially severe neurological damage if not managed correctly. This condition arises due to mutations in the UGT1A1 gene, which is crucial for bilirubin breakdown.
The test, available at DNA Labs UAE, involves a detailed analysis of the patient's DNA to identify mutations in the UGT1A1 gene. This genetic testing is critical for accurate diagnosis, allowing for tailored management and treatment plans to prevent complications associated with the syndrome. The cost of the Criggler Najjar Syndrome Test at DNA Labs UAE is 5400 AED, reflecting the sophisticated technology and expertise required to perform this specialized genetic analysis. Early diagnosis through this test can significantly improve the quality of life for individuals with Criggler-Najjar syndrome by facilitating early interventions.
The Extended AML (Acute Myeloid Leukemia) Panel is a comprehensive diagnostic test designed to detect specific genetic mutations and translocations associated with AML. This panel targets several key genes, including BCR-ABL, AML1-ETO (also known as RUNX1-RUNX1T1), CBFB, PML-RARA, FLT3, NPM1, and CEBPA. These genetic markers are crucial for diagnosing AML, determining prognosis, and guiding treatment decisions. The presence or absence of these mutations can significantly influence a patient's response to certain therapies, making this panel an essential tool in personalized medicine for AML patients.
Performed at DNA Labs UAE, a leading facility in genetic testing, the Extended AML Panel is executed with precision and accuracy, ensuring reliable results for patients and healthcare providers. The cost of the test is 5400 AED, reflecting the comprehensive nature of the analysis and the advanced technology employed in the process. By identifying specific genetic abnormalities, this test can help in tailoring treatment plans to the individual's genetic profile, potentially improving outcomes in AML treatment.
The "Liquid Bx. Cell-Free PAN RAS KRASNRAS Test" is an advanced diagnostic tool available at DNA Labs UAE, designed to detect mutations in the RAS gene family, which includes KRAS and NRAS genes, from a simple blood sample. This non-invasive test is particularly crucial for patients with various types of cancer, as mutations in these genes can influence tumor behavior and patient response to certain treatments. By analyzing cell-free DNA circulating in the bloodstream, the test offers a comprehensive overview of the genetic alterations present, enabling personalized treatment plans. The cost of the test is 5400 AED, reflecting its sophisticated technology and the invaluable insights it provides into the molecular profile of a patient's cancer, thereby guiding more effective treatment strategies.
Microarray 750K and Single Karyotyping AFCVSCBPOCPB Test is a comprehensive genetic test offered by DNA Labs UAE, designed to detect a wide range of genetic abnormalities and variations. This test utilizes advanced microarray technology capable of analyzing over 750,000 genetic markers, alongside single karyotyping techniques, to provide a detailed overview of an individual's genetic makeup. It is particularly useful in identifying genetic disorders, chromosomal abnormalities, and inherited diseases, thereby assisting in precise diagnosis and personalized treatment planning.
The test is priced at 5400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high accuracy and reliability of results. It is recommended for individuals seeking in-depth genetic analysis for health reasons, as well as for couples planning to conceive, to assess any potential genetic risks that could be passed on to their offspring. With its comprehensive approach, the Microarray 750K and Single Karyotyping AFCVSCBPOCPB Test stands as a pivotal tool in modern genetic diagnostics and personalized medicine.
The NTRK1, NTRK2, and NTRK3 test is a specialized diagnostic examination performed to detect alterations in the NTRK genes, which are critical for the development and function of the nervous system. These genes can also play a significant role in the formation and growth of certain types of cancer when they become fused with other genes, leading to the continuous activation of signaling pathways that promote tumor growth and survival. The test is particularly relevant for patients with cancers that are suspected to have NTRK gene fusions, as it can provide essential information for personalized treatment options, including the use of TRK inhibitors that specifically target these gene alterations.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the patient's DNA to identify the presence of any fusions involving the NTRK1, NTRK2, and NTRK3 genes. This process employs advanced molecular techniques to ensure high sensitivity and specificity in detecting these genetic abnormalities.
The cost of the NTRK1, NTRK2, and NTRK3 test at DNA Labs UAE is set at 5400 AED. While the price may seem significant, it reflects the complexity of the test and the profound impact its results can have on the management of cancer patients. By identifying NTRK gene fusions, oncologists can tailor treatment plans to exploit these genetic vulnerabilities, potentially improving patient outcomes with targeted therapies.
The Pre-implantation Genetic Diagnosis (PGD) Single Embryo Test is a sophisticated procedure offered by DNA Labs UAE, aimed at detecting genetic disorders in embryos before they are implanted. This test, which costs 5400 AED, is designed for couples undergoing in vitro fertilization (IVF) to ensure the health of their future child. By analyzing a single cell from an embryo, the PGD test can identify specific genetic conditions or chromosomal abnormalities, allowing only healthy embryos to be selected for implantation. This not only increases the chances of a successful pregnancy but also significantly reduces the risk of passing on inherited genetic disorders. DNA Labs UAE utilizes cutting-edge technology to provide accurate and reliable results, making it a preferred choice for couples seeking to minimize the risk of genetic diseases in their offspring.
The "Cancer Targeted Gene Panel Lung with PDL-1 DAKO Test" is a sophisticated diagnostic procedure offered by DNA Labs UAE, aimed at providing a comprehensive genetic analysis for individuals with lung cancer. This test is designed to identify specific genetic mutations and alterations in lung cancer cells, which can significantly influence treatment decisions and outcomes. By examining a panel of genes associated with lung cancer, the test helps in identifying the most effective targeted therapies for each patient, thereby personalizing treatment plans.
Additionally, the test includes the PDL-1 DAKO test, which measures the expression of the PD-L1 protein in tumor cells. PD-L1 expression is a critical factor in determining the suitability of immunotherapy, particularly with checkpoint inhibitors. This aspect of the test is vital for patients with non-small cell lung cancer (NSCLC), as it helps in identifying those who are likely to benefit from immunotherapies targeting the PD-1/PD-L1 pathway.
Conducted at DNA Labs UAE, a facility known for its advanced diagnostic technologies and expertise in genetic testing, the "Cancer Targeted Gene Panel Lung with PDL-1 DAKO Test" is priced at 5400 AED. This cost reflects the comprehensive nature of the test, encompassing both the targeted gene panel and the PD-L1 expression analysis, offering valuable insights that can guide the management and treatment of lung cancer in a personalized manner.
